









Markets
/
Stocks
/
nasdaq-mdwd
/

Mediwound Ltd

MDWD

View Detailed Chart

18.530USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

208.50MMarket Cap

LossP/E TTM



Mediwound Ltd

18.530

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-0.59%

5 Days

-8.85%

1 Month

-4.19%

6 Months

-3.24%

Year to Date

+4.10%

1 Year

+6.01%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts

BUY

Current Rating

30.667

Target Price

65.50%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Mediwound Ltd

MDWD

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(6)

Neutral(2)

Buy(1)

Indicators

Sell(1)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.409

Neutral

RSI(14)

35.761

Neutral

STOCH(KDJ)(9,3,3)

9.586

Oversold

ATR(14)

0.735

Low Volatility

CCI(14)

-210.074

Oversold

Williams %R

91.166

Oversold

TRIX(12,20)

-0.022

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

19.246

Sell

MA10

19.898

Sell

MA20

20.021

Sell

MA50

20.244

Sell

MA100

18.862

Sell

MA200

18.267

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.

Ticker SymbolMDWD

CompanyMediwound Ltd

CEOMr. Ofer Gonen

Websitehttps://www.mediwound.com/